Recent

% | $
Quotes you view appear here for quick access.

CombiMatrix Corporation Message Board

  • pll38 pll38 Dec 16, 2012 9:33 PM Flag

    Post reverse split run is coming! Shorts prepare yourselves!

    Taken from a Nov 26 Seeking Alpha article...

    "Some recent examples of large post reverse split runs are PURE Biosciences (PURE). After the reverse split on August 15, 2012, PURE moved from $1 to $1.68, a 68% move after a one month consolidation. Rosetta Genomics (ROSG) was a huge post reverse split runner back in May when it ran from $1.40 to $23.43 within a week. Over and over stocks, particularly biotech stocks, that implement reverse splits have large rallies within a month of the split."

    Sounds terrifying for a short guy! See ya at $30..........CBMX!.........COVER COVER COVER

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • ROSG dropped to $4 after that. What's your point?

      • 4 Replies to in4thedeal
      • Eventually Dropped to 4 yes, but it ran up 2x before it dropped. First time 1.5-7, then back to 4 for 2 days. Then went to 7, 11, 23 for the next 3 days, respectively.

        Sentiment: Strong Buy

      • What the point?

        "Making this statement were results from the study entitled "Chromosomal Microarray Versus Karyotyping for Prenatal Diagnosis," which enrolled a total of 4,406 women. Microarray analysis gave successful diagnostic results in 98.8 percent of women, and caught mistakes that were made with traditional karyotyping diagnostics. 755 women out of the population that had normal karyotypes were tested due to suspected growth or structural anomalies - 45 were found to have clinically relevant findings. Out of the total number of women that had normal karyotypes that implied standard indications for prenatal diagnosis, 1.7% of pregnancies were found to have clinically relevant information due to chromosomal microarray analysis."
        The recently published research could provide a much-needed lift to CombiMatrix's sales volumes which is why the stock had that pop to $14 the other day. This will be the standard test used by labs starting in 2013.
        When those reports start coming out the stock will explode! Mark this post.

        Sentiment: Strong Buy

      • You said: "ROSG dropped to $4 after that. What's your point?"

        I already made my point! I'm sorry you aren't able to understand...
        This company had huge news and when they start putting out the articles and show the profit potential of their technology this thing will be in the 20's or 30's!
        Microarray analysis will be the technology used in all labs eventually.
        This is from Dec. 11...
        "Helping this statement were results from the study entitled "Chromosomal Microarray Versus Karyotyping for Prenatal Diagnosis," which enrolled a total of 4,406 women. Microarray analysis gave successful diagnostic results in 98.8 percent of women, and caught mistakes that were made with traditional karyotyping diagnostics. 755 women out of the population that had normal karyotypes were tested due to suspected growth or structural anomalies - 45 were found to have clinically relevant findings. Out of the total number of women that had normal karyotypes that implied standard indications for prenatal diagnosis, 1.7% of pregnancies were found to have clinically relevant information due to chromosomal microarray analysis."

        Sentiment: Strong Buy

      • The point is VERY clear!
        CBMX has a much tighter float, much bigger potential for profits, huge insider ownership and will have lots of good news and upgrades coming out for the next couple of years.
        It's time to cover, son! Don't be last...

        Sentiment: Strong Buy

 
CBMX
2.9814+0.1214(+4.24%)11:16 AMEDT